Počet záznamov: 1
Advanced NSCLC treated with gefitinib or erlotinib for five years or longer - updated data from the retrospective Slovakian study
- Advanced NSCLC treated with gefitinib or erlotinib for five years or longer - updated data from the retrospective Slovakian study / Peter Beržinec, Peter Kasan, Juraj Mazal . Abstract IASLC 2019 World Conference on Lung Cancer [Dokument nie je vo fonde knižnice]
článok
Počet záznamov: 1